Business Context and Reporting Period
Alphatec Holdings, Inc. (ATEC) filed a Form 8-K on September 29, 2022, reporting the entry into a material definitive agreement. The company, incorporated in Delaware, operates in the medical device sector with principal executive offices in Carlsbad, California.
Key Financial Metrics and Debt Structure
The filing details a new asset-based revolving credit facility with the following terms:
- Facility Size: Maximum aggregate amount of $50 million, with an option to increase commitments by up to $25 million (total potential $75 million).
- Interest Rate: Term SOFR plus 3.5% per annum.
- Maturity Date: September 29, 2027, or 90 days prior to the final maturity of the Company's convertible senior notes due 2026, whichever is earlier.
- Borrowing Base: Calculated as 85% of Eligible Accounts Receivable plus 40% of Eligible Inventory (capped at the lesser of $15 million or 50% of the Borrowing Base), less reserves.
- Liquidity Covenant: Borrowers must maintain $10 million of liquidity at all times.
- Collateral: A continuing security interest in substantially all assets (excluding intellectual property) and a first priority lien on subsidiary equity interests.
The filing does not provide specific values for revenue, profit, cash flow, or margins as this is a current report regarding a financing event rather than a periodic financial statement.
Material Changes and Covenants
The primary material change is the establishment of the new debt facility to replace or supplement existing liquidity sources. The Credit Agreement imposes significant restrictions on the Company's operations, including:
- Limitations on incurring additional indebtedness and granting liens.
- Restrictions on mergers, consolidations, asset dispositions, and acquisitions.
- Prohibitions on paying dividends, making distributions, or repurchasing stock, subject to exceptions.
- Restrictions on entering into certain transactions with affiliates.
Outlook, Risks, and Use of Proceeds
Use of Proceeds: The Company intends to use the loan proceeds to pay transaction fees and for working capital needs and general corporate purposes.
Risks and Contingencies: The agreement contains customary events of default, including failure to make payments, bankruptcy, insolvency, or covenant breaches. Upon an event of default, lenders may accelerate obligations. The availability of funds is contingent on the Borrowing Base calculation, meaning the Company may not be able to access the full $50 million if eligible receivables or inventory levels are insufficient.
Investor Verification Checklist
- Verify the current levels of Eligible Accounts Receivable and Eligible Inventory to determine actual borrowing availability under the $50 million cap.
- Confirm the Company's current liquidity position to ensure compliance with the $10 million minimum liquidity covenant.
- Review the maturity date of the outstanding convertible senior notes due 2026 to understand the potential early termination date of this new facility.
- Assess the impact of the new covenants on the Company's ability to execute strategic initiatives such as acquisitions or stock repurchases.